Annual Total Long Term Liabilities
$18.75 M
+$15.38 M+457.75%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual total long term liabilities is $18.75 million, with the most recent change of +$15.38 million (+457.75%) on December 31, 2023.
- During the last 3 years, PRLD annual total long term liabilities has risen by +$18.71 million (+58481.25%).
- PRLD annual total long term liabilities is now -71.79% below its all-time high of $66.45 million, reached on December 31, 2019.
Performance
PRLD Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$18.57 M
-$115.00 K-0.62%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly total long term liabilities is $18.57 million, with the most recent change of -$115.00 thousand (-0.62%) on September 30, 2024.
- Over the past year, PRLD quarterly long term liabilities has dropped by -$164.00 thousand (-0.88%).
- PRLD quarterly long term liabilities is now -80.75% below its all-time high of $96.42 million, reached on June 30, 2020.
Performance
PRLD Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PRLD Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +457.8% | -0.9% |
3 y3 years | +10000.0% | +452.4% |
5 y5 years | -48.9% | +452.4% |
PRLD Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -100.0% | -1.0% | -100.0% |
5 y | 5-year | -71.8% | -100.0% | -80.8% | -100.0% |
alltime | all time | -71.8% | -100.0% | -80.8% | -100.0% |
Prelude Therapeutics Incorporated Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $18.57 M(-0.6%) |
Jun 2024 | - | $18.68 M(-0.3%) |
Mar 2024 | - | $18.73 M(-0.1%) |
Dec 2023 | $18.75 M(+457.8%) | $18.75 M(+457.8%) |
Sep 2023 | - | $3.36 M(0.0%) |
Jun 2023 | - | $3.36 M(0.0%) |
Mar 2023 | - | $3.36 M(0.0%) |
Dec 2022 | $3.36 M | $3.36 M(+0.0%) |
Sep 2022 | - | $3.36 M(+40.0%) |
Jun 2022 | - | $2.40 M(-14.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $2.79 M(>+9900.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2021 | - | $312.00 K(-42.5%) |
Jun 2021 | - | $543.00 K(-35.4%) |
Mar 2021 | - | $840.00 K(+2525.0%) |
Dec 2020 | $32.00 K(-100.0%) | $32.00 K(+113.3%) |
Sep 2020 | - | $15.00 K(-100.0%) |
Jun 2020 | - | $96.42 M(+45.1%) |
Dec 2019 | $66.45 M(+81.3%) | $66.45 M |
Dec 2018 | $36.65 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual total long term liabilities?
- What is the all time high annual total long term liabilities for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual total long term liabilities year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly long term liabilities year-on-year change?
What is Prelude Therapeutics Incorporated annual total long term liabilities?
The current annual total long term liabilities of PRLD is $18.75 M
What is the all time high annual total long term liabilities for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual total long term liabilities is $66.45 M
What is Prelude Therapeutics Incorporated annual total long term liabilities year-on-year change?
Over the past year, PRLD annual total long term liabilities has changed by +$15.38 M (+457.75%)
What is Prelude Therapeutics Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of PRLD is $18.57 M
What is the all time high quarterly long term liabilities for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly total long term liabilities is $96.42 M
What is Prelude Therapeutics Incorporated quarterly long term liabilities year-on-year change?
Over the past year, PRLD quarterly total long term liabilities has changed by -$164.00 K (-0.88%)